Healthcare & Pharma

Understand Competitor Moves Across Your Therapy Area

Monitor competitor launches, label news, patient and HCP conversation and policy changes across public sources — with aggregated insight built for compliance-aware teams.

Built for Healthcare Teams That Need Market Context With Appropriate Care

G24.8★★★★★rated on G2

Competitive Shifts Show Up in Public Conversation First

Lolly connects public discussion of treatments, competitors, access and policy so brand, medical and market access teams see how the landscape is changing — in aggregate.

Launches

See how rival launches and data readouts are received.

Patients

Understand experience themes across brands, in aggregate.

HCPs

Follow how professionals discuss treatment options.

Policy

Track pricing, access and regulatory conversation.

Bring Competitive Context to Every Brand Decision

01
02
03
04
05

Track Competitor Launches

Follow approvals, indication news, congress readouts and launches, and see how the conversation responds.

Benchmark Share of Voice

Compare conversation volume and themes by brand, therapy area or campaign across public sources.

Understand Patient Themes

See aggregated themes on access, cost, support and treatment experience across competing brands.

Follow HCP and Expert Discussion

Understand how healthcare professionals discuss competing data, guidelines and treatment choices.

Monitor Policy and Market Access

Watch pricing, reimbursement and regulatory conversation that can shift the competitive landscape.

Ask Ana+ New chatHistory
How is Rival A’s label expansion being discussed?

Rival A’s label expansion drove 2.3× more conversation, led by HCP accounts on X.

Access and cost are the top patient themes this month — 41% of brand conversation.

A pricing proposal in Germany is gaining coverage across trade and policy press.

2.3× conversation41% access and costGermany
Ask anything...

Your AI Analyst for Therapy Area Signals

Ask Ana how competitor news is received, what patients discuss and where the access conversation is moving.

  • Summarize reaction to a competitor readout
  • Compare share of voice by brand
  • Explain themes in patient conversation
  • Track policy and access discussion
  • Prepare briefings with sources for review
Ask Ana

From Public Signal to Reviewed Market Insight

01Define brands, therapy areas and topicsCompetitors, indications, policy terms.
02Detect launches, readouts and spikesAlerts as conversation builds.
03Compare brands and audiencesPatients, HCPs, media, policy.
04Review source examplesPublic posts and articles in context.
05Route findings through your review processTo brand, medical, access or comms.

Competitive Intelligence Across the Therapy Area

Launch Monitoring

See how competitor approvals and launches are discussed by patients, HCPs and media.

Congress Readouts

Follow expert reaction to competitor data at medical congresses and in journals.

Patient Themes

Compare aggregated experience themes on access, cost and support across brands.

Market Access

Watch reimbursement, pricing and policy talk that may shift your position.

Share of Voice

Benchmark awareness campaigns and disease-area conversation against competitors.

Misinformation

Spot misleading claims about your therapy area before they shape perception.

Questions We Get Asked First

Lolly analyzes publicly available conversation and reports themes in aggregate. It is not designed to identify or profile individual patients.

Lolly is not a pharmacovigilance system. Teams can route conversations that need review into their own adverse-event process.

Source, topic and keyword filters help teams look at professional, patient and media conversation separately.

You can track brand and generic names, indications, conditions and medical terms through custom keywords and topics.

Brand, competitive intelligence, medical affairs, market access and communications teams, with findings reviewed under their own governance.

See Your Therapy Area in Full Context

Understand competitor moves, patient themes and policy shifts across public conversation — with insight your teams can review.